Empowering GPOs and distributors with Rapid, High-Sensitivity Drug Detection Tools

FDA-cleared, CLIA-waived diagnostics made in the U.S.—deployed system-wide in minutes.

Why Instanosis

  • FDA Cleared, CLIA Waived (InstaStrip Fentanyl Urine)
  • 95% sensitivity and specificity vs. LC-MS/MS
  • Zero lab infrastructure required
  • Cost-effective and scalable across enterprise settings
  • Backed by NIH and validated by UCSF, Mayo, and Penn

Supports Triage, Toxicology, and Harm Reduction Across Care Settings

  • Emergency Departments
  • Psychiatric Units
  • Inpatient Pharmacies
  • Behavioral Health & Substance Use Clinics
  • Community Outreach and Harm Reduction

Flexible Terms, Secure Supply Chain, and GPO-Friendly Pricing

  • U.S. manufacturing = reliable fulfillment
  • Contract flexibility for system-wide deployment
  • Bulk pricing, formulary support, and value analysis materials available
  • Supports DEA/CDC/NIDA-aligned initiatives

FXN 3-in-1 Strip (Powder/Liquid)

View Product

Fentanyl/Xylazine/Nitazene test strips for forensic and harm reduction applications.

Detects: Fentanyl, Xylazine, Nitazene

Format: Single strip, field deployable

Use: Forensic/field screening

InstaStrip Fentanyl Rapid Test (FDA cleared, CLIA-Waived)

View Product

A dipstick test for the qualitative detection of Fentanyl in human urine.

Use: Point-of-care overdose screening

Detection: 1.0 ng/mL

CLIA-Waived | FDA Cleared

FXN 3-in-1 Kit

View Product

Fentanyl/Xylazine/Nitazene test strips for forensic and harm reduction applications.

Includes: Swabs, vials, droppers, instructions

Designed for sample prep without lab tools

Let’s Talk About Bringing Instanosis to Your Member Hospitals

800-946-5430 | 📧 support@instanosis.com